The medtech startup founded by physician and Farapulse inventor Steven Mickelsen is preparing to begin a pivotal study of pulsed field ablation for ventricular tachycardia.
The company said Stumpe’s promotion is a “pivotal step in [its] digital transformation and its ambition to lead the next era of innovation in life sciences and diagnostics.”
